Peter Wehrwein has been the lead editor of Managed Healthcare Executive since February 2020.
Amgen Launches Amjevita, First Humira Biosimilar on the U.S. Market
Amgen says it will sell the first biosimilar to Humira on the U.S. market at two prices.
Read More
Insurers Prepare to Fight RADV Rule
The Risk Adjustment Data Validation (RADV) rule was finalized today. The new rule for governing how CMS audits Medicare Advantage plans for overpayment due to inflated risk adjustment could cost insurers billions of dollars.